The Role of Microvasculature in Metastasis Formation

Vascular-Targeted Therapies in Oncology

Volumn , Issue , 2006, Pages 31-62

  Stoeltzing, Oliver ^a   Ellis, Lee M ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

'organ site' specific neoplastic microvasculature; Angiogenesis regulator in solid tumors; Extensive vascularization network; Extracellular matrix (ECM) invasion; hypoxia inducible factor 1 ; Microvasculature role in metastasis formation; Targeting neoplastic microvasculature; Tumor cell proliferation in primary lesion; Tumour angiogenesis and metastases formation; VEGF and tumour angiogenesis

Indexed keywords

EID: 33846210737     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470035439.ch3     Document Type: Chapter

References (142)

1. Achen, M.G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A.F., Alitalo, K. and Stacker, S.A. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95, 548-553.
2. Ahmad, S.A., Liu, W., Jung, Y.D., Fan, F., Wilson, M., Reinmuth, N., Shaheen, R.M., Bucana, C.D. and Ellis, L.M. (2001). The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res, 61, 1255-1259.
3. Akagi, Y., Liu, W., Xie, K., Zebrowski, B., Shaheen, R.M. and Ellis, L.M. (1999). Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1beta. Br J Cancer 80, 1506-1511.
4. Araya, M., Terashima, M., Takagane, A., Abe, K., Nishizuka, S., Yonezawa, H., Irinoda, T., Nakaya, T. and Saito, K. (1997). Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol 65, 232-236.
5. Arenberg, D.A., Kunkel, S.L., Polverini, P.J., Glass, M., Burdick, M.D. and Strieter, R.M. (1996). Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 97, 2792-2802.
6. Arteaga, C.L., Chinratanalab, W. and Carter, M.B. (2001). Inhibitors of HER2/neu (erbB-2) signal transduction. Semin Oncol 28, 30-35.
7. Balbay, M.D., Pettaway, C.A., Kuniyasu, H., Inoue, K., Ramirez, E., Li, E., Fidler, I.J. and Dinney, C.P. (1999). Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin Cancer Res 5, 783-789.
8. Bancroft, C.C., Chen, Z., Dong, G., Sunwoo, J.B., Yeh, N., Park, C. and Van Waes, C. (2001). Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin Cancer Res 7, 435-442.
9. Bancroft, C.C., Chen, Z., Yeh, J., Sunwoo, J.B., Yeh, N.T., Jackson, S., Jackson, C. and Van Waes, C. (2002). Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 99, 538-548.
10. Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E. and Hanahan, D. (2003). Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111, 1287-1295.
11. Bergsten, E., Uutela, M., Li, X., Pietras, K., Ostman, A., Heldin, C.H., Alitalo, K. and Eriksson, U. (2001). PDGF-D is a specific, protease-activated ligand for the PDGF betareceptor. Nat Cell Biol 3, 512-516.
12. Bermont, L., Lamielle, F., Fauconnet, S., Esumi, H., Weisz, A. and Adessi, G.L. (2000). Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells. Int J Cancer 85, 117-123.
13. Brooks, P.C., Clark, R.A. and Cheresh, D.A. (1994). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569-571.
14. Bruns, C.J., Harbison, M.T., Davis, D.W., Portera, C.A., Tsan, R., McConkey, D.J., Evans, D.B., Abbruzzese, J.L., Hicklin, D.J. and Radinsky, R. (2000). Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res 6, 1936-1948.
15. Cao, R., Brakenhielm, E., Li, X., Pietras, K., Widenfalk, J., Ostman, A., Eriksson, U. and Cao, Y. (2002). Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB J 16, 1575-1583.
16. Carmeliet, P. and Jain, R.K. (2000). Angiogenesis in cancer and other diseases. Nature 407, 249-257.
17. Cheung, N., Wong, M.P., Yuen, S.T., Leung, S.Y. and Chung, L.P. (1998). Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. Hum Pathol 29, 910-914.
18. Chevalier, S., Defoy, I., Lacoste, J., Hamel, L., Guy, L., Begin, L.R. and Aprikian, A.G. (2002). Vascular endothelial growth factor and signaling in the prostate: more than angiogenesis. Mol Cell Endocrinol 189, 169-179.
19. Danilkovitch-Miagkova, A. and Zbar, B. (2002). Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 109, 863-867.
20. Dong, G., Chen, Z., Li, Z.Y., Yeh, N.T., Bancroft, C.C. and Van Waes, C. (2001). Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 61, 5911-5918.
21. Du, J.R., Jiang, Y., Zhang, Y.M. and Fu, H. (2003). Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. World J Gastroenterol 9, 1604-1606.
22. Duque, J.L., Loughlin, K.R., Adam, R.M., Kantoff, P.W., Zurakowski, D. and Freeman, M.R. (1999). Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology 54, 523-527.
23. Dvorak, H.F., Detmar, M., Claffey, K.P., Nagy, J.A., van de Water, L. and Senger, D.R. (1995). Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107, 233-235.
24. Ellis, L.M., Ahmad, S., Fan, F., Liu, W., Jung, Y.D., Stoeltzing, O., Reinmuth, N. and Parikh, A.A. (2002). Angiopoietins and their role in colon cancer angiogenesis. Oncology (Huntingt) 16, 31-35.
25. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J. and Moore, M.W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
26. Ferrara, N. and Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocr Rev 18, 4-25.
27. Ferrara, N. and Henzel, W.J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161, 851-858.
28. Fidler, I.J. (1995). Critical factors in the biology of human cancer metastasis. Am Surg 61, 1065-1066.
29. Fidler, I.J. and Ellis, L.M. (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188.
30. Fidler, I.J., Singh, R.K., Yoneda, J., Kumar, R., Xu, L., Dong, Z., Bielenberg, D.R., McCarty, M. and Ellis, L.M. (2000). Critical determinants of neoplastic angiogenesis. Cancer J 6 (SUPPL. 3), S225-S236.
31. Folkman, J. (1990). What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82, 4-6.
32. Folkman, J. (1992). The role of angiogenesis in tumor growth. Semin Cancer Biol 3, 65-71.
33. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1, 27-31.
34. Fontanini, G., Vignati, S., Boldrini, L., Chine, S., Silvestri, V., Lucchi, M., Mussi, A., Angeletti, C.A. and Bevilacqua, G. (1997). Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 3, 861-865.
35. Friedlander, M., Theesfeld, C.L., Sugita, M., Fruttiger, M., Thomas, M.A., Chang, S. and Cheresh, D.A. (1996). Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci USA 93, 9764-9769.
36. Fukuda, R., Hirota, K., Fan, F., Jung, Y.D., Ellis, L.M. and Semenza, G.L. (2002). Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277, 38205-38211.
37. Galligioni, E. and Ferro, A. (2001). Angiogenesis and antiangiogenic agents in non-small cell lung cancer. Lung Cancer 34 (SUPPL. 4), S3-S7.
38. Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V. and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3¢-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273, 30336-30343.
39. Gervaz, P., Scholl, B., Mainguene, C., Poitry, S., Gillet, M. and Wexner, S. (2000). Angiogenesis of liver metastases: role of sinusoidal endothelial cells. Dis Colon and Rectum 43, 980-986.
40. Gunningham, S.P., Currie, M.J., Han, C., Robinson, B.A., Scott, P.A., Harris, A.L. and Fox, S.B. (2001). VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. J Pathol 193, 325-332.
41. Guo, P., Hu, B., Gu, W., Xu, L., Wang, D., Huang, H.J., Cavenee, W.K. and Cheng, S.Y. (2003). Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 162, 1083-1093.
42. Hattori, K., Muta, M., Toi, M., Iizasa, H., Shinsei, M., Terasaki, T., Obinata, M., Ueda, M. and Nakashima, E. (2001). Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats. Pharm Res 18, 9-15.
43. Hayes, D.F. (1994). Angiogenesis and breast cancer. Hematol Oncol Clin North Am 8, 51-71.
44. Helmlinger, G., Yuan, F., Dellian, M. and Jain, R.K. (1997). Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3, 177-182.
45. Holash, J., Wiegand, S.J. and Yancopoulos, G.D. (1999). New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18, 5356-5362.
46. Houck, K.A., Ferrara, N., Winer, J., Cachianes, G., Li, B. and Leung, D.W. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5, 1806-1814.
47. Huang, S., DeGuzman, A., Bucana, C.D. and Fidler, I.J. (2000). Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res 6, 2573-2581.
48. Huang, S.P., Wu, M.S., Wang, H.P., Yang, C.S., Kuo, M.L. and Lin, J.T. (2002). Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma. J Gastroenterol Hepatol 17, 1165-1169.
49. Hynes, R.O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25.
50. Ikeda, N., Adachi, M., Taki, T., Huang, C., Hashida, H., Takabayashi, A., Sho, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., Nakano, H. and Miyake, M. (1999). Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79, 1553-1563.
51. Inoue, K., Slaton, J.W., Eve, B.Y., Kim, S.J., Perrotte, P., Balbay, M.D., Yano, S., Bar-Eli, M., Radinsky, R., Pettaway, C.A. and Dinney, C.P. (2000). Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 6, 2104-2119.
52. Ivaska, J. and Heino, J. (2000). Adhesion receptors and cell invasion: mechanisms of integringuided degradation of extracellular matrix. Cell Mol Life Sci 57, 16-24.
53. Jung, Y.D., Ahmad, S.A., Akagi, Y., Takahashi, Y., Liu, W., Reinmuth, N., Shaheen, R.M., Fan, F. and Ellis, L.M. (2000). Role of the tumor microenvironment in mediating response to anti-angiogenic therapy. Cancer and Metastasis Rev 19, 147-157.
54. Kasahara, T., Mukaida, N., Yamashita, K., Yagisawa, H., Akahoshi, T. and Matsushima, K. (1991). IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74, 60-67.
55. Keck, P.J., Hauser, S.D., Krivi, G., Sanzo, K., Warren, T., Feder, J. and Connolly, D.T. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.
56. Keyt, B.A., Berleau, L.T., Nguyen, H.V., Chen, H., Heinsohn, H., Vandlen, R. and Ferrara, N. (1996). The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271, 7788-7795.
57. Kido, S., Kitadai, Y., Hattori, N., Haruma, K., Kido, T., Ohta, M., Tanaka, S., Yoshihara, M., Sumii, K., Ohmoto, Y. and Chayama, K. (2001). Interleukin 8 and vascular endothelial growth factor-prognostic factors in human gastric carcinomas? Eur J Cancer 37, 1482-1487.
58. Kim, L.S., Huang, S., Lu, W., Lev, D.C. and Price, J.E. (2004a). Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin Exp Metastasis 21, 107-118.
59. Kim, S.J., Uehara, H., Yazici, S., Langley, R.R., He, J., Tsan, R., Fan, D., Killion, J.J. and Fidler, I.J. (2004b). Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice. Cancer Res 64, 4201-4208.
60. Kitadai, Y., Ellis, L.M., Takahashi, Y., Bucana, C.D., Anzai, H., Tahara, E. and Fidler, I.J. (1995). Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin Cancer Res 1, 1095-1102.
61. Kitadai, Y., Haruma, K., Tokutomi, T., Tanaka, S., Sumii, K., Carvalho, M., Kuwabara, M., Yoshida, K., Hirai, T., Kajiyama, G. and Tahara, E. (1998). Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res 4, 2195-2200.
62. Klapper, L.N., Kirschbaum, M.H., Sela, M. and Yarden, Y. (2000). Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res 77, 25-79.
63. Kondo, Y., Arii, S., Mori, A., Furutani, M., Chiba, T. and Imamura, M. (2000). Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Clin Cancer Res 6, 622-630.
64. Kotsuji-Maruyama, T., Imakado, S., Kawachi, Y. and Otsuka, F. (2002). PDGF-BB induces MAP kinase phosphorylation and VEGF expression in neurofibroma-derived cultured cells from patients with neurofibromatosis 1. J Dermatol 29, 713-717.
65. Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marme, D. and Gastl, G. (1999). Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85, 178-187.
66. Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I. and Plate, K.H. (2000). Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19, 5435-5443.
67. Kumar, R. and Yarmand-Bagheri, R. (2001). The role of HER2 in angiogenesis. Semin Oncol 28, 27-32.
68. Laughner, E., Taghavi, P., Chiles, K., Mahon, P.C. and Semenza, G.L. (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21, 3995-4004.
69. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V. and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
70. Linder, S., Blasjo, M., von Rosen, A., Parrado, C., Falkmer, U.G. and Falkmer, S. (2001). Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients. Pancreas 22, 240-247.
71. Maeda, K., Chung, Y.S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., Arimoto, Y. and et al. (1995). Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13, 477-481.
72. Maehara, Y., Kabashima, A., Koga, T., Tokunaga, E., Takeuchi, H., Kakeji, Y. and Sugimachi, K. (2000). Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 128, 408-416.
73. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N., Daly, T.J., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.
74. Masui, T., Hosotani, R., Doi, R., Miyamoto, Y., Tsuji, S., Nakajima, S., Kobayashi, H., Koizumi, M., Toyoda, E., Tulachan, S.S. and Imamura, M. (2002). Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction. Anticancer Res 22, 4093-4100.
75. Matsushima, K., Baldwin, E.T. and Mukaida, N. (1992). Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol 51, 236-265.
76. Meert, A.P., Paesmans, M., Martin, B., Delmotte, P., Berghmans, T., Verdebout, J.M., Lafitte, J.J., Mascaux, C. and Sculier, J.P. (2002). The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87, 694-701.
77. Miyamoto, S., Teramoto, H., Gutkind, J.S. and Yamada, K.M. (1996). Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol 135, 1633-1642.
78. Monestiroli, S., Mancuso, P., Burlini, A., Pruneri, G., Dell'Agnola, C., Gobbi, A., Martinelli, G. and Bertolini, F. (2001). Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res 61, 4341-4344.
79. Moriyama, T., Kataoka, H., Hamasuna, R., Yokogami, K., Uehara, H., Kawano, H., Goya, T., Tsubouchi, H., Koono, M. and Wakisaka, S. (1998). Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 249, 73-77.
80. Nagy, J.A., Masse, E.M., Herzberg, K.T., Meyers, M.S., Yeo, K.T., Yeo, T.K., Sioussat, T.M. and Dvorak, H.F. (1995). Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 55, 360-368.
81. Neuchrist, C., Erovic, B.M., Handisurya, A., Fischer, M.B., Steiner, G.E., Hollemann, D., Gedlicka, C., Saaristo, A. and Burian, M. (2003). Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 25, 464-474.
82. Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13, 9-22.
83. Nguyen, D.M. and Schrump, D.S. (2004). Growth factor receptors as targets for lung cancer therapy. Semin Thorac Cardiovasc Surg 16, 3-12.
84. Oh, J.S., Kucab, J.E., Bushel, P.R., Martin, K., Bennett, L., Collins, J., DiAugustine, R.P., Barrett, J.C., Afshari, C.A. and Dunn, S.E. (2002). Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia 4, 204-217.
85. Paget, S. (1989). The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8, 98-101.
86. Pardanaud, L., Altmann, C., Kitos, P., Dieterlen-Lievre, F. and Buck, C.A. (1987). Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. Development 100, 339-349.
87. Parikh, A.A., Fan, F., Liu, W.B., Ahmad, S.A., Stoeltzing, O., Reinmuth, N., Bielenberg, D., Bucana, C.D., Klagsbrun, M. and Ellis, L.M. (2004). Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 164, 2139-2151.
88. Park, J.E., Keller, G.A. and Ferrara, N. (1993). The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4, 1317-1326.
89. Partanen, J., Armstrong, E., Makela, T.P., Korhonen, J., Sandberg, M., Renkonen, R., Knuutila, S., Huebner, K. and Alitalo, K. (1992). A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12, 1698-1707.
90. Partanen, T.A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S.A., Achen, M.G. and Alitalo, K. (2000). VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14, 2087-2096.
91. Petit, A.M., Rak, J., Hung, M.C., Rockwell, P., Goldstein, N., Fendly, B. and Kerbel, R.S. (1997). Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 151, 1523-1530.
92. Plouet, J., Schilling, J. and Gospodarowicz, D. (1989). Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8, 3801-3806.
93. Rajesh, L., Joshi, K., Bhalla, V., Dey, P., Radotra, B.D. and Nijhawan, R. (2004). Correlation between VEGF expression and angiogenesis in breast carcinoma. Anal Quant Cytol Histol 26, 105-108.
94. Reinmuth, N., Fan, F., Liu, W., Parikh, A.A., Stoeltzing, O., Jung, Y.D., Bucana, C.D., Radinsky, R., Gallick, G.E. and Ellis, L.M. (2002). Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82, 1377-1389.
95. Reinmuth, N., Liu, W., Jung, Y.D., Ahmad, S.A., Shaheen, R.M., Fan, F., Bucana, C.D., McMahon, G., Gallick, G.E. and Ellis, L.M. (2001). Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15, 1239-1241.
96. Reinmuth, N., Parikh, A.A., Ahmad, S.A., Liu, W., Stoeltzing, O., Fan, F., Takeda, A., Akagi, M. and Ellis, L.M. (2003). Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc Res Tech 60, 199-207.
97. Sato, N., Mizumoto, K., Beppu, K., Maehara, N., Kusumoto, M., Nabae, T., Morisaki, T., Katano, M. and Tanaka, M. (2000). Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential. Cancer Lett 155, 153-161.
98. Schackert, G., Price, J.E., Bucana, C.D. and Fidler, I.J. (1989). Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice. Int J Cancer 44, 892-897.
99. Senger, D.R., Claffey, K.P., Benes, J.E., Perruzzi, C.A., Sergiou, A.P. and Detmar, M. (1997). Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA 94, 13612-13617.
100. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S. and Dvorak, H.F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
101. Senger, D.R., Perruzzi, C.A., Feder, J. and Dvorak, H.F. (1986). A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46, 5629-5632.
102. Senger, D.R., Van de Water, L., Brown, L.F., Nagy, J.A., Yeo, K.T., Yeo, T.K., Berse, B., Jackman, R.W., Dvorak, A.M. and Dvorak, H.F. (1993). Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12, 303-324.
103. Sengupta, S., Gherardi, E., Sellers, L.A., Wood, J.M., Sasisekharan, R. and Fan, T.P. (2003a). Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 23, 69-75.
104. Sengupta, S., Sellers, L.A., Li, R.C., Gherardi, E., Zhao, G., Watson, N., Sasisekharan, R. and Fan, T.P. (2003b). Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. Circulation 107, 2955-2961.
105. Shaheen, R.M., Tseng, W.W., Davis, D.W., Liu, W., Reinmuth, N., Vellagas, R., Wieczorek, A.A., Ogura, Y., McConkey, D.J., Drazan, K.E., Bucana, C.D., McMahon, G. and Ellis, L.M. (2001). Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res 61, 1464-1468.
106. Shi, Q., Abbruzzese, J.L., Huang, S., Fidler, I.J., Xiong, Q. and Xie, K. (1999). Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 5, 3711-3721.
107. Shibata, A., Nagaya, T., Imai, T., Funahashi, H., Nakao, A. and Seo, H. (2002). Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat 73, 237-243.
108. Smith, L.E., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., Schaeffer, J.M. and Senger, D.R. (1999). Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5, 1390-1395.
109. Soker, S., Miao, H.Q., Nomi, M., Takashima, S. and Klagsbrun, M. (2002). VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem 85, 357-368.
110. Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G. and Bussolino, F. (1999). Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18, 882-892.
111. Staton, C.A., Stribbling, S.M., Tazzyman, S., Hughes, R., Brown, N.J. and Lewis, C.E. (2004). Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85, 233-248.
112. Stefanou, D., Batistatou, A., Arkoumani, E., Ntzani, E. and Agnantis, N.J. (2004). Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in small-cell and non-small-cell lung carcinomas. Histol Histopathol 19, 37-42.
113. Stoeltzing, O., Ahmad, S.A., Liu, W., McCarty, M.F., Parikh, A.A., Fan, F., Reinmuth, N., Bucana, C.D. and Ellis, L.M. (2002). Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. Br J Cancer 87, 1182-1187.
114. Stoeltzing, O., Ahmad, S.A., Liu, W., McCarty, M.F., Wey, J.S., Parikh, A.A., Fan, F., Reinmuth, N., Kawaguchi, M., Bucana, C.D. and Ellis, L.M. (2003a). Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res 63, 3370-3377.
115. Stoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parikh, A.A., Bucana, C.D., Evans, D.B., Semenza, G.L. and Ellis, L.M. (2003b). Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am J Pathol 163, 1001-1011.
116. Sugino, T., Kusakabe, T., Hoshi, N., Yamaguchi, T., Kawaguchi, T., Goodison, S., Sekimata, M., Homma, Y. and Suzuki, T. (2002). An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am J Pathol 160, 1973-1980.
117. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
118. Takahashi, Y., Cleary, K.R., Mai, M., Kitadai, Y., Bucana, C.D. and Ellis, L.M. (1996). Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2, 1679-1684.
119. Takahashi, Y., Kitadai, Y., Bucana, C.D., Cleary, K.R. and Ellis, L.M. (1995). Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55, 3964-3968.
120. Takebayashi, Y., Aklyama, S., Yamada, K., Akiba, S. and Aikou, T. (1996). Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 78, 226-231.
121. Terayama, N., Terada, T. and Nakanuma, Y. (1996a). Histologic growth patterns of metastatic carcinomas of the liver. Japan J Clin Oncol 26, 24-29.
122. Terayama, N., Terada, T. and Nakanuma, Y. (1996b). An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue. Histopathology 29, 37-43.
123. Uehara, H., Kim, S.J., Karashima, T., Shepherd, D.L., Fan, D., Tsan, R., Killion, J.J., Logothetis, C., Mathew, P. and Fidler, I.J. (2003). Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J Natl Cancer Inst 95, 458-470.
124. Ushijima, C., Tsukamoto, S., Yamazaki, K., Yoshino, I., Sugio, K. and Sugimachi, K. (2001). High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression. Lung Cancer 34, 233-241.
125. Vermeulen, P.B., Van den Eynden, G.G., Huget, P., Goovaerts, G., Weyler, J., Lardon, F., Van Marck, E., Hubens, G. and Dirix, L.Y. (1999). Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 79, 316-322.
126. Walton, H.L., Corjay, M.H., Mohamed, S.N., Mousa, S.A., Santomenna, L.D. and Reilly, T.M. (2000). Hypoxia induces differential expression of the integrin receptors alpha(vbeta3) and alpha(vbeta5) in cultured human endothelial cells. J Cell Biochem 78, 674-680.
127. Wang, G.L., Jiang, B.H., Rue, E.A. and Semenza, G.L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92, 5510-5514.
128. Warren, R.S., Yuan, H., Matli, M.R., Ferrara, N. and Donner, D.B. (1996). Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 271, 29483-29488.
129. Wei, L.H., Kuo, M.L., Chen, C.A., Cheng, W.F., Cheng, S.P., Hsieh, F.J. and Hsieh, C.Y. (2001). Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 82, 49-56.
130. Wei, L.H., Kuo, M.L., Chen, C.A., Chou, C.H., Lai, K.B., Lee, C.N. and Hsieh, C.Y. (2003). Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22, 1517-1527.
131. Weidner, N., Semple, J.P., Welch, W.R. and Folkman, J. (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324, 1-8.
132. Xiangming, C., Hokita, S., Natsugoe, S., Tanabe, G., Baba, M., Takao, S., Kuroshima, K. and Aikou, T. (1998). Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer. Ann Surg Oncol 5, 585-589.
133. Xu, L., Yoneda, J., Herrera, C., Wood, J., Killion, J.J. and Fidler, I.J. (2000). Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. Int J Oncol 16, 445-454.
134. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J. and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
135. Yang, W., Klos, K., Yang, Y., Smith, T.L., Shi, D. and Yu, D. (2002). ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer 94, 2855-2861.
136. Yano, S., Nokihara, H., Yamamoto, A., Goto, H., Ogawa, H., Kanematsu, T., Miki, T., Uehara, H., Saijo, Y., Nukiwa, T. and Sone, S. (2003). Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion-and angiogenesis-related molecules. Cancer Sci 94, 244-252.
137. Yen, L., You, X.L., Al Moustafa, A.E., Batist, G., Hynes, N.E., Mader, S., Meloche, S. and Alaoui-Jamali, M.A. (2000). Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene 19, 3460-3469.
138. Yuan, A., Yu, C.J., Chen, W.J., Lin, F.Y., Kuo, S.H., Luh, K.T. and Yang, P.C. (2000). Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 89, 475-483.
139. Yuan, A., Yu, C.J., Luh, K.T., Kuo, S.H., Lee, Y.C. and Yang, P.C. (2002). Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol 20, 900-910.
140. Zebrowski, B.K., Yano, S., Liu, W., Shaheen, R.M., Hicklin, D.J., Putnam, J.B., Jr. and Ellis, L.M. (1999). Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 5, 3364-3368.
141. Zhang, H., Wu, J., Meng, L. and Shou, C.C. (2002). Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J Gastroenterol 8, 994-998.
142. Zhong, H., De Marzo, A.M., Laughner, E., Lim, M., Hilton, D.A., Zagzag, D., Buechler, P., Isaacs, W.B., Semenza, G.L. and Simons, J.W. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59, 5830-5835.